Protocol for large scale whole blood immune monitoring by mass cytometry and Cyto Quality Pipeline

STAR Protoc. 2022 Oct 31;3(4):101697. doi: 10.1016/j.xpro.2022.101697. eCollection 2022 Dec 16.

Abstract

Mass cytometry (MC) is a powerful large-scale immune monitoring technology. To maximize MC data quality, we present a protocol for whole blood analysis together with an R package, Cyto Quality Pipeline (CytoQP), which minimizes the experimental artifacts and batch effects to ensure data reproducibility. We describe the steps to stimulate, fix, and freeze blood samples before acquisition to make them suitable for retrospective studies. We then detail the use of barcoding and reference samples to facilitate multicenter and multi-batch experiments. For complete details on the use and execution of this protocol, please refer to Rybakowska et al. (2021a) and (2021b).

Keywords: Clinical protocol; Flow cytometry/Mass cytometry; Immunology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Flow Cytometry / methods
  • Leukocytes, Mononuclear*
  • Monitoring, Immunologic
  • Multicenter Studies as Topic
  • Reproducibility of Results
  • Retrospective Studies